What CACI International (CACI)'s New Defense Contracts and Expanded Credit Lines Mean For Shareholders

• CACI International recently announced multiple past developments, including two new multi-year U.S. defense task orders worth up to US$145,000,000 and US$79,000,000, and a Second Amended and Restated Credit Agreement providing a US$1.25 billion term loan plus a US$2.00 billion revolving facility maturing in 2030.
• Together with an earlier earnings report showing double-digit revenue growth and strong free cash flow, these contracts and expanded credit lines highlight CACI’s reinforced role in high-value defense technology and its increased financial flexibility for future initiatives.
• We’ll now examine how this combination of fresh Navy and Army contract wins could influence CACI’s investment narrative around backlog quality and growth.

AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

CACI International Investment Narrative Recap

To own CACI International, you need to believe that demand for complex U.S. defense, intelligence, and C5ISR work will keep translating into long, sticky contracts and steady backlog conversion. The newest Navy and Army task orders reinforce this thesis but do not materially change the main near term swing factor, which remains how consistently CACI can turn its growing backlog into earnings while managing its high debt load and exposure to U.S. federal budget decisions.

Among the latest announcements, the Second Amended and Restated Credit Agreement stands out for investors. By securing a US$1.25 billion term loan and a US$2.00 billion revolving facility maturing in 2030, CACI has expanded its financial flexibility to support large, tech heavy programs, which sits directly alongside the earnings growth catalyst of winning and executing higher value defense technology contracts.

Yet beneath these supportive trends, investors still need to watch how CACI’s high reliance on U.S. government spending could...

Read the full narrative on CACI International (it's free!)

CACI International’s narrative projects $10.4 billion revenue and $634.1 million earnings by 2028. This requires 6.5% yearly revenue growth and an earnings increase of about $134 million from $499.8 million today.

Uncover how CACI International's forecasts yield a $658.91 fair value, a 9% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community span roughly US$457 to US$733 per share, showing how far opinions can stretch. You might set those views against CACI’s dependence on U.S. defense and intelligence budgets, and then decide which future you find most convincing.

Explore 4 other fair value estimates on CACI International - why the stock might be worth 25% less than the current price!

Build Your Own CACI International Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your CACI International research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free CACI International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CACI International's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.
• These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• We've found 15 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.